Homechoice Health Services- Hattiesburg | |
22 Millbranch Road, Suite 100, Hattiesburg, Mississippi 39402 | |
(601) 268-8450 | |
Name | Homechoice Health Services- Hattiesburg |
---|---|
Location | 22 Millbranch Road, Suite 100, Hattiesburg, Mississippi |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 257123 |
Ownership Type | Proprietary |
Service Area Zip Codes | 39362, 39401, 39402, 39403, 39423, 39425, 39426, 39429, 39451, 39452, 39455, 39456, 39464, 39465, 39466, 39470, 39475, 39476, 39482, 39483, 39501, 39502, 39503, 39507, 39520, 39530, 39531, 39532, 39540, 39553, 39560, 39561, 39563, 39564, 39565, 39567, 39571, 39573, 39574, 39577, 39581, 39643 |
NPI Number | 1023077310 |
Organization Name | HATTIESBURG HOME CARE SERVICES LLC |
Doing Business As | WESLEY HOME CARE |
Address | 22 Millbranch Rd Ste 1200, Hattiesburg, MS 39402 |
Phone Number | 601-620-0971 |
News Archive
Stemedica Cell Technologies, Inc. received the FDA's investigational new drug (IND) approval for a United States-based, Phase IIa clinical study using its allogeneic stem-cell therapy to treat subjects with mild to moderate dementia due to Alzheimer's disease (AD), the sixth leading cause of death in the United States.
More than 900 scientists, parents and activists from around the world who are focused on understanding the causes of autism and finding treatments for the developmental disorder will gather in Seattle May 3-5 to share the latest research findings at the sixth annual International Meeting for Autism Research.
Scientists are beginning to unravel the question why people distinctly vary in size. In cooperation with scientists of the HelmholtzZentrum Munchen, an international genome-wide study has discovered ten new genes that influence body height and thus provides new insights into biological pathways that are important for human growth.
UNION therapeutics A/S (UNION) announced today that the results of a phase 1 study of inhaled and intranasal niclosamide (UNI911) have been published by The Lancet Regional Health – Europe.
Some adults and children with acute leukemia could benefit from certain transplants of blood stem cells, but the benefits are not equal across all cases of leukemia, according to a new review of 15 studies.
› Verified 4 days ago
Quality Rating: |
News Archive
Stemedica Cell Technologies, Inc. received the FDA's investigational new drug (IND) approval for a United States-based, Phase IIa clinical study using its allogeneic stem-cell therapy to treat subjects with mild to moderate dementia due to Alzheimer's disease (AD), the sixth leading cause of death in the United States.
More than 900 scientists, parents and activists from around the world who are focused on understanding the causes of autism and finding treatments for the developmental disorder will gather in Seattle May 3-5 to share the latest research findings at the sixth annual International Meeting for Autism Research.
Scientists are beginning to unravel the question why people distinctly vary in size. In cooperation with scientists of the HelmholtzZentrum Munchen, an international genome-wide study has discovered ten new genes that influence body height and thus provides new insights into biological pathways that are important for human growth.
UNION therapeutics A/S (UNION) announced today that the results of a phase 1 study of inhaled and intranasal niclosamide (UNI911) have been published by The Lancet Regional Health – Europe.
Some adults and children with acute leukemia could benefit from certain transplants of blood stem cells, but the benefits are not equal across all cases of leukemia, according to a new review of 15 studies.
› Verified 4 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 99.3 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 99.4 | 98.6 |
How often the home health team checked patients’ risk of falling | 99.9 | 99.6 |
How often the home health team checked patients for depression | 98.9 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 86.9 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 93.8 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 99.8 | 96.4 |
News Archive
Stemedica Cell Technologies, Inc. received the FDA's investigational new drug (IND) approval for a United States-based, Phase IIa clinical study using its allogeneic stem-cell therapy to treat subjects with mild to moderate dementia due to Alzheimer's disease (AD), the sixth leading cause of death in the United States.
More than 900 scientists, parents and activists from around the world who are focused on understanding the causes of autism and finding treatments for the developmental disorder will gather in Seattle May 3-5 to share the latest research findings at the sixth annual International Meeting for Autism Research.
Scientists are beginning to unravel the question why people distinctly vary in size. In cooperation with scientists of the HelmholtzZentrum Munchen, an international genome-wide study has discovered ten new genes that influence body height and thus provides new insights into biological pathways that are important for human growth.
UNION therapeutics A/S (UNION) announced today that the results of a phase 1 study of inhaled and intranasal niclosamide (UNI911) have been published by The Lancet Regional Health – Europe.
Some adults and children with acute leukemia could benefit from certain transplants of blood stem cells, but the benefits are not equal across all cases of leukemia, according to a new review of 15 studies.
› Verified 4 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 89.7 | 79.6 |
How often patients got better at getting in and out of bed | 86.1 | 81.1 |
How often patients got better at bathing | 89.1 | 82.3 |
How often patients’ breathing improved | 92.4 | 82.8 |
How often patients’ wounds improved or healed after an operation | 98 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 85.5 | 75 |
How often home health patients had to be admitted to the hospital | 15.6 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 17 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 97.9 | 94 |
News Archive
Stemedica Cell Technologies, Inc. received the FDA's investigational new drug (IND) approval for a United States-based, Phase IIa clinical study using its allogeneic stem-cell therapy to treat subjects with mild to moderate dementia due to Alzheimer's disease (AD), the sixth leading cause of death in the United States.
More than 900 scientists, parents and activists from around the world who are focused on understanding the causes of autism and finding treatments for the developmental disorder will gather in Seattle May 3-5 to share the latest research findings at the sixth annual International Meeting for Autism Research.
Scientists are beginning to unravel the question why people distinctly vary in size. In cooperation with scientists of the HelmholtzZentrum Munchen, an international genome-wide study has discovered ten new genes that influence body height and thus provides new insights into biological pathways that are important for human growth.
UNION therapeutics A/S (UNION) announced today that the results of a phase 1 study of inhaled and intranasal niclosamide (UNI911) have been published by The Lancet Regional Health – Europe.
Some adults and children with acute leukemia could benefit from certain transplants of blood stem cells, but the benefits are not equal across all cases of leukemia, according to a new review of 15 studies.
› Verified 4 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
Stemedica Cell Technologies, Inc. received the FDA's investigational new drug (IND) approval for a United States-based, Phase IIa clinical study using its allogeneic stem-cell therapy to treat subjects with mild to moderate dementia due to Alzheimer's disease (AD), the sixth leading cause of death in the United States.
More than 900 scientists, parents and activists from around the world who are focused on understanding the causes of autism and finding treatments for the developmental disorder will gather in Seattle May 3-5 to share the latest research findings at the sixth annual International Meeting for Autism Research.
Scientists are beginning to unravel the question why people distinctly vary in size. In cooperation with scientists of the HelmholtzZentrum Munchen, an international genome-wide study has discovered ten new genes that influence body height and thus provides new insights into biological pathways that are important for human growth.
UNION therapeutics A/S (UNION) announced today that the results of a phase 1 study of inhaled and intranasal niclosamide (UNI911) have been published by The Lancet Regional Health – Europe.
Some adults and children with acute leukemia could benefit from certain transplants of blood stem cells, but the benefits are not equal across all cases of leukemia, according to a new review of 15 studies.
› Verified 4 days ago
The patient survey data of Homechoice Health Services- Hattiesburg is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 91 | 88 |
Percent of patients who reported that their home health team communicated well with them | 89 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 89 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 85 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 74 | 78 |
News Archive
Stemedica Cell Technologies, Inc. received the FDA's investigational new drug (IND) approval for a United States-based, Phase IIa clinical study using its allogeneic stem-cell therapy to treat subjects with mild to moderate dementia due to Alzheimer's disease (AD), the sixth leading cause of death in the United States.
More than 900 scientists, parents and activists from around the world who are focused on understanding the causes of autism and finding treatments for the developmental disorder will gather in Seattle May 3-5 to share the latest research findings at the sixth annual International Meeting for Autism Research.
Scientists are beginning to unravel the question why people distinctly vary in size. In cooperation with scientists of the HelmholtzZentrum Munchen, an international genome-wide study has discovered ten new genes that influence body height and thus provides new insights into biological pathways that are important for human growth.
UNION therapeutics A/S (UNION) announced today that the results of a phase 1 study of inhaled and intranasal niclosamide (UNI911) have been published by The Lancet Regional Health – Europe.
Some adults and children with acute leukemia could benefit from certain transplants of blood stem cells, but the benefits are not equal across all cases of leukemia, according to a new review of 15 studies.
› Verified 4 days ago
Encompass Health-home Health & Hospice Location: 133 Mayfair Road, Hattiesburg, Mississippi 39402 Ratings: Phone: (601) 268-0408 | |
Homechoice Health Services- Hattiesburg Location: 22 Millbranch Road, Suite 100, Hattiesburg, Mississippi 39402 Ratings: Phone: (601) 268-8450 | |
Forrest General Home Care Location: 1414 South 28th Avenue, Hattiesburg, Mississippi 39402 Ratings: Phone: (601) 288-4344 |